Noninvasive electrocardiographic mapping to improve patient selection for cardiac resynchronization therapy: beyond QRS duration and left bundle branch block morphology.

OBJECTIVES This study sought to investigate whether noninvasive electrocardiographic activation mapping is a useful method for predicting response to cardiac resynchronization therapy (CRT). BACKGROUND One third of the patients appear not to respond to CRT when they are selected according to QRS duration. METHODS We performed electrocardiographic activation mapping in 33 consecutive CRT candidates (QRS duration ≥120 ms). In 18 patients, the 12-lead electrocardiographic morphology was left bundle branch block (LBBB), and in 15, it was nonspecific intraventricular conduction disturbance (NICD). Three indexes of electrical dyssynchrony were derived from intrinsic maps: right and left ventricular total activation times and ventricular electrical uncoupling (VEU) (difference between the left ventricular [LV] and right ventricular mean activation times). We assessed the ability of these parameters to predict response, measured using a clinical composite score, after 6 months of CRT. RESULTS Electrocardiographic maps revealed homogeneous patterns of activation and consistently greater VEU and LV total activation time (LVTAT) in patients with LBBB compared with heterogeneous activation sequences and shorter VEU and LVTAT in NICD patients (VEU: 75 ± 12 ms vs. 40 ± 22 ms; p < 0.001; LVTAT: 115 ± 21 ms vs. 91 ± 34 ms; p = 0.03). LBBB and NICD patients had similar right ventricular total activation times (62 ± 30 ms vs. 58 ± 26 ms; p = 0.7). The area under the receiver-operating characteristic curve indicated that VEU (area under the curve [AUC]: 0.88) was significantly superior to QRS duration (AUC: 0.73) and LVTAT (AUC: 0.72) for predicting CRT response (p < 0.05). With a 50-ms cutoff value, VEU identified CRT responders with 90% sensitivity and 82% specificity whether LBBB was present or not. CONCLUSIONS Ventricular electrical uncoupling measured by electrocardiographic mapping predicted clinical CRT response better than QRS duration or the presence of LBBB.

[1]  John L Sapp,et al.  Cardiac-resynchronization therapy for mild-to-moderate heart failure. , 2010, The New England journal of medicine.

[2]  Angelo Auricchio,et al.  Characterization of Left Ventricular Activation in Patients With Heart Failure and Left Bundle-Branch Block , 2004, Circulation.

[3]  K. Dickstein,et al.  The European cardiac resynchronization therapy survey. , 2009, European heart journal.

[4]  S. Solomon,et al.  Right ventricular dysfunction and adverse outcome in patients with advanced heart failure. , 2006, Journal of cardiac failure.

[5]  AngeloAuricchio,et al.  Characterization of Left Ventricular Activation in Patients With Heart Failure and Left Bundle-Branch Block , 2004 .

[6]  J. Sanderson,et al.  Variable left ventricular activation pattern in patients with heart failure and left bundle branch block , 2003, Heart.

[7]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[8]  Jeroen J. Bax,et al.  Results of the Predictors of Response to CRT (PROSPECT) Trial , 2008, Circulation.

[9]  Maria Drangova,et al.  Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. , 2006, Journal of the American College of Cardiology.

[10]  E. W. Hancock,et al.  AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American , 2009, Journal of the American College of Cardiology.

[11]  J. Daubert,et al.  Responders to cardiac resynchronization therapy with narrow or intermediate QRS complexes identified by simple echocardiographic indices of dyssynchrony: The DESIRE study , 2008, European journal of heart failure.

[12]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[13]  Paul J. Wang,et al.  Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT) , 2011, Circulation.

[14]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[15]  Y. Rudy,et al.  Activation and repolarization of the normal human heart under complete physiological conditions. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[16]  K. Rosen,et al.  Epicardial Activation in Patients with Left Bundle Branch Block , 1980, Circulation.

[17]  David O. Martin,et al.  Cardiac Resynchronization Therapy in Non‐Left Bundle Branch Block Morphologies , 2009, Pacing and clinical electrophysiology : PACE.

[18]  N. Varma.  Left ventricular conduction delays and relation to QRS configuration in patients with left ventricular dysfunction. , 2009, The American journal of cardiology.

[19]  D. Simon,et al.  Effect of QRS Morphology on Clinical Event Reduction With Cardiac Resynchronization Therapy: Meta-Analysis of Randomized Controlled Trials , 2011 .

[20]  Jeroen J. Bax,et al.  Analysis of Ventricular Activation Using Surface Electrocardiography to Predict Left Ventricular Reverse Volumetric Remodeling During Cardiac Resynchronization Therapy , 2010, Circulation.

[21]  Stefano Ghio,et al.  Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. , 2008, Journal of the American College of Cardiology.

[22]  D. Rowland,et al.  Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. , 2012, American heart journal.

[23]  Jagmeet P. Singh,et al.  Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy. , 2006, Heart rhythm.

[24]  Nancy M Albert,et al.  Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee. , 2012, Journal of cardiac failure.

[25]  J. Conti,et al.  Cardiac resynchronization therapy in patients with heart failure and conduction abnormalities other than left bundle‐branch block: Analysis of the multicenter insync randomized clinical evaluation (MIRACLE) , 2004, Clinical cardiology.

[26]  J. Lumens,et al.  Acute hemodynamic response to biventricular pacing in heart failure patients with narrow, moderately, and severely prolonged QRS duration. , 2012, Heart rhythm.

[27]  M. Packer,et al.  Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. , 2001, Journal of cardiac failure.

[28]  Y. Rudy,et al.  Electrocardiographic imaging of cardiac resynchronization therapy in heart failure: observation of variable electrophysiologic responses. , 2006, Heart rhythm.